Article 20 Jun 2025 Health Canada Proposes To Remove Phase III Trial Requirement From Biosimilar Approval Pathway Canada Healthcare
Article 04 Mar 2024 Federal Court Of Appeal Addresses Patentability Of Methods Of Medical Treatment In Canada Canada IP
Article 31 Oct 2022 Crocs Successfully Asserts Industrial Design, Awarded Infringer's Profits Canada IP
Article 15 Jun 2022 Promise Me No Promises? The Five-year Anniversary Of The Supreme Court's AstraZeneca Decision Canada IP
Article 30 Dec 2021 Amendments To The Patented Medicines Regulations Delayed Six Months, Until July 1, 2022 Canada IP